Inventor
JAVIER MORALES
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
C12NMicroorganisms or enzymes10%
PatentTitleYear
12,479,924Constructs specifically recognizing Glypican 3 and uses thereof202512,168,696Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating MUC16-positive cancer202411,827,672Constructs trageting CD22 and uses thereof202311,613,573Chimeric antibody/T-cell receptor constructs and uses thereof202311,447,564Constructs specifically recognizing glypican 3 and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to EUREKA THERAPEUTICS INC (5)· patent assignee history
2022–2025Based in US· patent location history
2024Patents assigned to MEMORIAL SLOAN KETTERING CANCER CENTER (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EUREKA THERAPEUTICS INC | 5 | 2022–2025 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |